Skip to content
GERICLINICS

GeriQBank · Paper III · Q4

Reversible / treatable dementias — investigation and management

Very High YieldAsked ×37-mark note
Topic
Dementia & Cognition
Chapter
Dementia & Cognitive Disorders
Years asked
Not recorded in the source
Frequency
Set 3× in Paper III (2009–2025)

As set in the university paper

  • What are the reversible / treatable dementias? How would you investigate and manage them, and what investigations rule them out?

    Paper III · Cognition, Dementia & Delirium · asked ×3 · 7-mark note · see in paper list

Answer framework

  1. Definition and scale — reversible versus non-reversible dementia; how rare true reversal is; reversal not guaranteed
  2. Causes — neoplastic, metabolic and endocrine, nutritional, trauma, toxins, drugs, infection, autoimmune, psychiatric, other (NPH, sleep apnoea, sensory deprivation)
  3. Depressive pseudodementia — clinical pointers and prognosis
  4. Investigation — blood panel, imaging, neuropsychological testing
  5. Management — deprescribe, treat depression, correct deficiencies, surgical referral, treat infections, control vascular risk
  6. Recent updates — the PENS trial for NPH, autoimmune encephalitis, rapidly progressive dementia, Beers 2023, sensory loss, Indian context

An exam answer plan drawn from the detailed answer below. Use it to attempt the question first.

Detailed answer

Pro · free in beta
Attempt it firstOutline your answer as a 7-mark note before revealing it — definition, causes, evaluation, management and the geriatric angle.Reveal answer

Short revision answer

  • Truly reversible dementia is under 4% of cases, but treatable contributors are common. Finding a cause does not guarantee recovery: B12 and thyroid replacement have not been shown to reverse established deficits.
  • Causes (DEMENTIA): drugs and depression; endocrine (hypothyroidism, hyperparathyroidism); metabolic (sodium, calcium, uraemia, liver failure); eyes and ears; nutrition (B12, folate, thiamine) and NPH; tumour and trauma (chronic subdural haematoma); infection (HIV, syphilis, TB meningitis) and autoimmune disease; alcohol and toxins.
  • Drugs are the commonest and easiest reversible contributor — anticholinergics first.
  • Depressive pseudodementia: prominent memory complaints, patchy deficits, "don't know" answers. Depression coexists in more than one-third of outpatients with dementia, and those with reversible impairment while depressed are at high risk of later dementia.
  • Investigations: blood count, glucose, urea, electrolytes, calcium and phosphate, liver tests, TSH, B12, and syphilis and HIV serology if suspected; CT or MRI for recent onset or focal signs (subdural haematoma, tumour, NPH).
  • Neuropsychological testing helps when baseline ability is high or low and in separating depression from dementia.
  • Management: stop offending drugs, ask about alcohol, treat depression (citalopram, sertraline, mirtazapine), correct deficiencies and electrolytes, refer NPH and subdural haematoma for neurosurgical assessment, treat infections and control vascular risk.
  • Do not diagnose dementia during delirium.
  • Updates: PENS (2025) — shunting for NPH improves gait (80% vs 24%) but not cognition or continence; autoimmune encephalitis (LGI1, CASPR2, NMDAR, GAD65) responds to immunotherapy; decline within 12 months is rapidly progressive dementia needing urgent work-up; hearing aids (ACHIEVE) slow decline in at-risk people.

Condensed by GeriClinics from the detailed answer below, with no new facts added.

RECURRING TOPIC ALERT — Reversible dementias appear repeatedly in MD Geriatrics papers, usually as a 15-mark long question or as a “how will you investigate a patient with cognitive decline” case. Additional recall scaffolding is given at the end of this answer.

15–20 High-Yield Points

A. DEFINITION AND SCALE OF THE PROBLEM

1.

Dementia in older people is grouped into reversible or partially reversible and non-reversible types. The reversible group is the clinically indispensable minority: they are few in number but represent the cases where diagnosis changes outcome.

2.

Reversible dementia accounts for probably less than 4% of cases. However, concurrent medical conditions causing mild cognitive disturbance are much commoner and are potentially treatable — identifying them avoids unnecessary disability and misdiagnosis even when cognition does not fully normalise.

3.

An important caveat: finding a reversible cause does not guarantee that the dementia will improve once that cause is treated. Thyroid hormone and vitamin B12 replacement may be important for general health but have not been shown to reverse established cognitive deficits.

B. CAUSES — THE CLASSIFIED LIST

4.

Neoplasms — primary and secondary intracranial tumours, and paraneoplastic/limbic encephalitis.

5.

Metabolic and endocrine disorders — hypothyroidism, hyperparathyroidism, hyponatraemia, hypercalcaemia, hepatic and renal failure, hypoglycaemia.

6.

Nutritional disorders — vitamin B12 deficiency, folate deficiency, thiamine deficiency (Wernicke–Korsakoff syndrome), pellagra.

7.

Trauma — chronic subdural haematoma, post-traumatic states, dementia pugilistica (the last irreversible).

8.

Toxins — alcoholism, heavy metals (lead, mercury, arsenic, manganese), organic poisons.

9.

Drugs — the single most important reversible cause in practice: anticholinergics and antihistamines, narcotic and non-narcotic analgesics, NSAIDs, anticonvulsants, antihypertensives, antiparkinsonian drugs, digoxin, antiarrhythmics, H2 receptor antagonists, antianxiety drugs, antidepressants, antipsychotics, sedative-hypnotics, skeletal muscle relaxants, steroids and alcohol.

10.

Infections — HIV and opportunistic infections, neurosyphilis, tuberculous meningitis, chronic fungal meningitis, viral encephalitis, Whipple’s disease.

11.

Autoimmune disorders — CNS vasculitis, temporal arteritis, systemic lupus erythematosus, multiple sclerosis, and autoimmune encephalitis.

12.

Psychiatric disorders — depression (“depressive pseudodementia”).

13.

Other — normal-pressure hydrocephalus, obstructive sleep apnoea, and severe sensory deprivation from uncorrected hearing and visual loss.

C. DEPRESSIVE PSEUDODEMENTIA — A SPECIAL CASE

14.

Depression coexists with dementia in more than one-third of outpatients with dementia and in an even greater proportion in nursing homes. Many patients with early dementia become depressed, and depression may be diagnosed before dementia becomes evident.

15.

Clinical pointers to depression as the cause: prominent complaints of memory loss (contrast with the concealment typical of AD), patchy and inconsistent cognitive deficits on examination, and frequent “don’t know” answers. Detailed neuropsychological testing helps, and where doubt persists, a careful trial of an antidepressant is justified both diagnostically and therapeutically.

16.

Important prognostic point: older patients who develop reversible cognitive impairment while depressed are at relatively high risk of developing dementia over the following few years and need close cognitive follow-up.

D. INVESTIGATION

17.

These disorders are detected by careful history, physical examination and selected laboratory studies. The recommended panel is: complete blood count, glucose, blood urea nitrogen, electrolytes (sodium and potassium in mEq/L), calcium and phosphorus (mg/dL), liver function tests, thyroid-stimulating hormone (µIU/mL), vitamin B12 (pg/mL), serological test for syphilis if suspected, and HIV antibodies if suspected.

18.

CT or MRI of the head should be performed to exclude unsuspected correctable structural lesions in patients with dementia of recent onset in whom no other clinical finding explains the dementia, and in those with focal neurological signs or symptoms — chiefly to exclude subdural haematoma, tumour and normal-pressure hydrocephalus. CT and MRI are roughly equivalent for detecting remediable structural lesions; MRI shows more lesions in multi-infarct dementia but also white-matter changes of uncertain significance.

19.

Neuropsychological testing is valuable when the mental status score is normal but function or behaviour has changed (high baseline intelligence), when the score is low without functional deficit (low educational level), and specifically for differentiating depression from dementia.

E. MANAGEMENT

20.

Withdraw or substitute every drug that may be worsening cognition, especially those with strong anticholinergic activity, and maintain a high index of suspicion for excessive alcohol intake, which is easily missed and causes dementia, delirium, depression and falls. Treat depression energetically with an SSRI such as citalopram or sertraline, or the NaSSA mirtazapine, all of which have minimal cognitive side effects. Correct B12 deficiency, hypothyroidism, hyponatraemia and hypercalcaemia; refer NPH for shunt assessment and chronic subdural haematoma for neurosurgical evaluation; treat neurosyphilis, HIV and tuberculous meningitis specifically; and control vascular risk factors, especially hypertension, which may favourably influence the course of both degenerative and vascular cognitive impairment.

Latest Updates (2023–Present)

Shunting for iNPH now has randomised placebo-controlled proof. The PENS trial (NEJM, 2025; 99 patients, 17 centres) compared open with placebo shunt settings: gait velocity improved by 0.21 m/s more with an open shunt (p<0.001), and 80% of the open-shunt group achieved meaningful improvement versus 24% with placebo, with better balance and fewer falls. Cognition and continence did not improve significantly — an important nuance. This settles the long-standing debate and strengthens the case for shunting the one classically reversible dementia.

Autoimmune and antibody-mediated encephalitis is now firmly established as a treatable cause of subacute cognitive decline in older adults — LGI1, CASPR2, NMDAR and GAD65 antibodies should be tested when there is rapid progression over weeks to months, seizures (especially faciobrachial dystonic seizures with LGI1), hyponatraemia, movement disorder or psychiatric prominence; immunotherapy can produce dramatic recovery. Rapidly progressive dementia is a recognised diagnostic emergency: the working rule is that decline to dementia within 12 months mandates urgent search for autoimmune, infective, neoplastic, metabolic and toxic causes before accepting Creutzfeldt–Jakob disease, using CSF RT-QuIC, 14-3-3, autoantibody panels and MRI DWI. Deprescribing has been formalised. The AGS Beers Criteria (2023 update) reinforce avoidance of strongly anticholinergic drugs, benzodiazepines, Z-drugs and first-generation antihistamines in older adults, and anticholinergic burden scales (ACB, ARS) are now recommended for routine calculation in memory clinics. Obstructive sleep apnoea and untreated hearing and vision loss have moved from footnote to mainstream: the Lancet Commission 2024 added untreated vision loss as a modifiable risk factor, and ACHIEVE (2023) showed hearing aids slowed cognitive decline in older adults at increased risk. Both are practical, high-yield reversible contributors in Indian practice.

Indian context: B12 deficiency and hypothyroidism are disproportionately common, given widespread vegetarianism and iodine-related thyroid disease, making the B12/TSH pair particularly high-yield in Indian memory clinics. Neurosyphilis, HIV-associated neurocognitive disorder and tuberculous meningitis remain far commoner reversible causes here than in Western series. NPHCE district geriatric units and ICOPE screening are the practical platform for early detection.

Current Practice Update

Current evidence and guidelines (2023

Area Textbook position onward)

NPH shunting Surgery, with risk–benefit carefully PENS trial (2025) — randomised, placebo-assessed; efficacy debated controlled proof of gait benefit; cognition and continence do not reliably improve Autoimmune causes CNS vasculitis, SLE, MS listed Antibody-mediated encephalitis (LGI1, CASPR2, NMDAR, GAD65) now a defined, immunotherapy-responsive category B12 and thyroid replacement Not shown to reverse cognitive deficits Position unchanged; treat for general health and to prevent further decline, not with the expectation of cognitive reversal Sensory impairment Sensory deprivation noted as contributory ACHIEVE (2023): hearing aids slow decline in at-risk elders; vision loss added to Lancet Commission list (2024)

Drug-induced cognitive impairment List of offending drug classes Formalised through AGS Beers 2023 and routine anticholinergic burden scoring with structured deprescribing Extra Recall Points — Recurring Topic MNEMONIC FOR REVERSIBLE DEMENTIAS: “DEMENTIA”

Letter Cause

D Drugs (anticholinergics, sedatives, opioids, steroids) and Depression E Emotional (pseudodementia) and Endocrine (hypothyroidism, hyperparathyroidism)

M Metabolic (Na⁺, Ca²⁺, uraemia, hepatic failure)

E Eyes and Ears — sensory deprivation

N Nutritional (B12, folate, thiamine) and Normal-pressure hydrocephalus T Tumour, Trauma (chronic subdural haematoma)

I Infection (HIV, syphilis, TB meningitis) and

Inflammatory/autoimmune

A Alcohol and toxins

NUMERICAL ANCHORS

Reversible dementia: <4% of all dementias

Depression coexists in >1/3 of dementia outpatients Rapidly progressive dementia = decline to dementia in <12 months PENS trial: gait velocity gain 0.21 m/s; 80% vs 24% meaningful improvement NAMED ENTITIES TO QUOTE Clarfield’s analyses (small proportion truly reversible) · Hospital Elder Life Program (HELP) for delirium prevention overlap · PENS trial 2025 · ACHIEVE 2023 · AGS Beers Criteria 2023 · Lancet Commission 2024 COMMON EXAMINER TRAPS

1.

Saying reversible dementias are common — they are <4%; the value of the search is that the yield, though small, is decisive.

2.

Claiming B12 and thyroid replacement reverse dementia — the textbook explicitly states they have not been shown to do so.

3.

Forgetting that drugs are the commonest single reversible contributor and the easiest to correct.

4.

Omitting normal-pressure hydrocephalus and chronic subdural haematoma — both are surgically treatable.

5.

Diagnosing dementia during an episode of delirium — the diagnosis of dementia must await treatment of all potentially reversible causes of delirium.

6.

Failing to mention that treating a reversible cause may not restore cognition but still prevents excess disability.

15-SECOND ANSWER SKELETON

Define → state <4% truly reversible but always worth seeking → classify causes (drugs, depression, metabolic/endocrine, nutritional, structural, infective, autoimmune, NPH) → investigation panel (bloods + TSH + B12 + CT/MRI) → management (deprescribe, treat depression, correct deficiencies, surgical referral for NPH and subdural, control vascular risk) → caveat that reversal is not guaranteed → Indian angle (B12, hypothyroidism, neurosyphilis, HIV, TB meningitis).

Exam One-Liners <4% of dementias are truly reversible; concurrent treatable conditions are far commoner. Finding the cause does not guarantee reversal.

Drugs are the commonest reversible contributor — anticholinergics first.

Depressive pseudodementia: prominent memory complaints, patchy deficits, “don’t know” answers. Depression coexists with dementia in over one-third of outpatients.

Panel: CBC, glucose, urea, electrolytes, calcium/phosphorus, LFT, TSH, B12, VDRL and HIV if suspected, CT/MRI head.

CT and MRI are equivalent for detecting remediable structural lesions.

Structural causes to exclude: subdural haematoma, tumour, NPH.

Treated depression with cognitive impairment → high risk of later dementia; follow up closely. PENS 2025: shunting improves gait, not cognition or continence.

How was your recall?

Rating marks the question complete. “Need another pass” also adds it to your bookmarks.

References

Spotted an error or something out of date?Report a problem with this page